FIELD: medicine; operative dentistry. SUBSTANCE: during performance of complex antibacterial and infusion therapy injections of 1 ml of 1-% solution of nicotine acid are included in complex of treatment measures in the course of 5 days from moment of hospitalization. EFFECT: reduced contact temperatures indicating normalization of disturbed tissue exchange. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING ACUTE ODONTOGENIC INFLAMMATION FOCUS STATE | 1997 |
|
RU2132068C1 |
| METHOD FOR TREATING PURULENT WOUNDS IN MAXILLOFACIAL REGION | 1999 |
|
RU2159086C1 |
| METHOD OF PREDICTING CONSEQUENCES OF GRAVE INFLAMMATORY DISEASES OF MAXILLOFACIAL AREA | 1996 |
|
RU2123697C1 |
| METHOD FOR TREATING ODONTOGENOUS ADENOPHLEGMON | 2002 |
|
RU2210378C1 |
| METHOD OF TREATMENT OF MAXILLOFACIAL INFLAMMATORY DISEASES | 2006 |
|
RU2330644C1 |
| METHOD OF MAXILLOFACIAL PHLEGMONS TREATMENT | 2007 |
|
RU2328292C1 |
| METHOD FOR COMPLEX THERAPY OF AVERAGE-DEGREE ORAL PHLEGMONS | 2007 |
|
RU2320329C1 |
| METHOD FOR TREATING ODONTOGENIC PHLEGMON-COMPLICATED OSTEOMYELITIS | 2001 |
|
RU2232029C2 |
| METHOD FOR TREATING ABSCESSES, SOFT TISSUE PHLEGMONS | 2006 |
|
RU2284825C1 |
| METHOD FOR PREDICTING ACUTE ODONTOGENIC ABSCESS-COMPLICATED OSTEOMYELITIS AND ACUTE ODONTOGENIC PHLEGMON-COMPLICATED OSTEOMYELITIS | 2002 |
|
RU2221252C1 |
